AdaptHealth Corp. (AHCO) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AHCO Revenue Growth
Revenue Breakdown (FY 2025)
AHCO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
AHCO Revenue Analysis (2017–2025)
As of May 8, 2026, AdaptHealth Corp. (AHCO) generated trailing twelve-month (TTM) revenue of $2.86 billion, reflecting explosive growth of +41.2% year-over-year. The most recent quarter (Q1 2026) recorded $819.8 million in revenue, down 3.1% sequentially.
Looking at the longer-term picture, AHCO's 5-year compound annual growth rate (CAGR) stands at +25.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $3.26 billion in 2024.
Revenue diversification analysis shows AHCO's business is primarily driven by Respiratory Health (100%). With over half of revenue concentrated in Respiratory Health, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HCSG (+7.1% YoY), OPCH (+9.3% YoY), and EHAB (+3.2% YoY), AHCO has outperformed the peer group in terms of revenue growth. Compare AHCO vs HCSG →
AHCO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AHCOCurrent | $2.9B | +41.2% | +25.2% | 5.7% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 OPCH | $5.6B | +9.3% | +13.3% | 6.0% | |
 EHAB | $1.1B | +3.2% | -0.3% | 6.0% | |
 PTCT | $1.7B | -53.3% | +35.4% | 49.5% | |
 PHG | $17.8B | -1.0% | +0.6% | 8.0% |
AHCO Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.24B | -0.5% | $568.6M | 17.5% | $186.3M | 5.7% |
| 2024 | $3.26B | +1.9% | $681.1M | 20.9% | $263.7M | 8.1% |
| 2023 | $3.20B | +7.7% | $681.8M | 21.3% | $-598,401,000 | -18.7% |
| 2022 | $2.97B | +21.0% | $417.4M | 14.1% | $190.4M | 6.4% |
| 2021 | $2.45B | +132.4% | $445.6M | 18.2% | $225.6M | 9.2% |
| 2020 | $1.06B | +99.5% | $157.8M | 14.9% | $71.3M | 6.8% |
| 2019 | $529.6M | +53.4% | $88.9M | 16.8% | $29.4M | 5.5% |
| 2018 | $345.3M | +79.3% | $60.1M | 17.4% | $-1,233,716 | -0.4% |
| 2017 | $192.6M | - | $29.7M | 15.4% | $-690 | -0.0% |
See AHCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHCO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAHCO — Frequently Asked Questions
Quick answers to the most common questions about buying AHCO stock.
Is AHCO's revenue growth accelerating or slowing?
AHCO revenue is accelerating at +41.2% year-over-year, exceeding the 5-year CAGR of +25.2%. TTM revenue reached $2.9B. Growth momentum has increased versus prior periods.
What is AHCO's long-term revenue growth rate?
AdaptHealth Corp.'s 5-year revenue CAGR of +25.2% reflects the sustained expansion pattern. Current YoY growth of +41.2% is above this long-term average.
How is AHCO's revenue distributed by segment?
AHCO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.